Differential immune response of adipocytes to virulent and attenuated Mycobacterium tuberculosis

Microbes and Infection

Volumn 13, Issue 14-15, 2011, Pages 1242-1251

  Kim, Jong Seok ^a   Ryu, Min Jeong ^b   Byun, Eui Hong ^a   Kim, Woo Sik ^a   Whang, Jake ^a   Min, Ki Nam ^a   Shong, Minho ^b   Kim, Hwa Jung ^a   Shin, Sung Jae ^a  

^a Research Center for Endocrine and Metabolic Diseases   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Adipocyte; Cytokine; Mycobacterium tuberculosis; Nitric oxide

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; LACTATE DEHYDROGENASE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL DEATH; CELL DIVISION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNE RESPONSE; IN VITRO STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BLOTTING, WESTERN; EXTRACELLULAR SPACE; FORMALDEHYDE; HOT TEMPERATURE; HUMANS; IMMUNE EVASION; INTERLEUKIN-10; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; MICE; MICROSCOPY, FLUORESCENCE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 81155150121     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.07.002     Document Type: Article

References (45)

1. Desruisseaux M.S., Nagajyothi, Trujillo M.E., Tanowitz H.B., Scherer P.E. Adipocyte, adipose tissue, and infectious disease. Infect. Immun. 2007, 75:1066-1078.
2. Szendrodi J., Roden M. The adipose tissue as an endocrine organ. Acta Med. Austriaca 2004, 31:98-111.
3. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol. Cell Endocrinol. 2010, 316:129-139.
4. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005, 115:911-919. quiz 920.
5. Bechah Y., Paddock C.D., Capo C., Mege J.L., Raoult D. Adipose tissue serves as a reservoir for recrudescent Rickettsia prowazekii infection in a mouse model. PLoS One 2010, 5:e8547.
6. Combs T.P., Nagajyothi, Mukherjee S., de Almeida C.J., Jelicks L.A., Schubert W., Lin Y., Jayabalan D.S., Zhao D., Braunstein V.L., Landskroner-Eiger S., Cordero A., Factor S.M., Weiss L.M., Lisanti M.P., Tanowitz H.B., Scherer P.E. The adipocyte as an important target cell for Trypanosoma cruzi infection. J. Biol. Chem. 2005, 280:24085-24094.
7. Neyrolles O., Hernandez-Pando R., Pietri-Rouxel F., Fornes P., Tailleux L., Barrios Payan J.A., Pivert E., Bordat Y., Aguilar D., Prevost M.C., Petit C., Gicquel B. Is adipose tissue a place for Mycobacterium tuberculosis persistence?. PLoS One 2006, 1:e43.
8. Nagajyothi F., Desruisseaux M.S., Thiruvur N., Weiss L.M., Braunstein V.L., Albanese C., Teixeira M.M., de Almeida C.J., Lisanti M.P., Scherer P.E., Tanowitz H.B. Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obes. (Silver Spring) 2008, 16:1992-1997.
9. Frieden T.R., Sterling T.R., Munsiff S.S., Watt C.J., Dye C. Tuberculosis. Lancet 2003, 362:887-899.
10. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nat. Rev. Immunol. 2001, 1:20-30.
11. Parrish N.M., Dick J.D., Bishai W.R. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 1998, 6:107-112.
12. Opie E.L. Pathology of the tuberculosis of Childhood and its Bearing on clinical work. Br. Med. J. 1927, 2:1130-1135.
13. Hernandez-Pando R., Jeyanathan M., Mengistu G., Aguilar D., Orozco H., Harboe M., Rook G.A., Bjune G. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000, 356:2133-2138.
14. McKinney J.D., Honer zu Bentrup K., Munoz-Elias E.J., Miczak A., Chen B., Chan W.T., Swenson D., Sacchettini J.C., Jacobs W.R., Russell D.G. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000, 406:735-738.
15. Erol A. Visceral adipose tissue specific persistence of Mycobacterium tuberculosis may be reason for the metabolic syndrome. Med. Hypotheses 2008, 71:222-228.
16. Farer L.S., Lowell A.M., Meador M.P. Extrapulmonary tuberculosis in the United States. Am. J. Epidemiol. 1979, 109:205-217.
17. Nugent C., Prins J.B., Whitehead J.P., Savage D., Wentworth J.M., Chatterjee V.K., O'Rahilly S. Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol. Endocrinol. 2001, 15:1729-1738.
18. Campbell R.E., Tour O., Palmer A.E., Steinbach P.A., Baird G.S., Zacharias D.A., Tsien R.Y. A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. U S A 2002, 99:7877-7882.
19. Shin S.J., Han J.H., Manning E.J., Collins M.T. Rapid and reliable method for quantification of Mycobacterium paratuberculosis by use of the BACTEC MGIT 960 system. J. Clin. Microbiol. 2007, 45:1941-1948.
20. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U S A 1987, 84:9265-9269.
21. Freeman S., Post F.A., Bekker L.G., Harbacheuski R., Steyn L.M., Ryffel B., Connell N.D., Kreiswirth B.N., Kaplan G. Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. J. Interferon Cytokine Res. 2006, 26:27-33.
22. Mehebik N., Jaubert A.M., Sabourault D., Giudicelli Y., Ribiere C. Leptin-induced nitric oxide production in white adipocytes is mediated through PKA and MAP kinase activation. Am. J. Physiol. Cell Physiol. 2005, 289:C379-C387.
23. Silver R.F., Li Q., Ellner J.J. Expression of virulence of Mycobacterium tuberculosis within human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun. 1998, 66:1190-1199.
24. Chan E.D., Chan J., Schluger N.W. What is the role of nitric oxide in murine and human host defense against tuberculosis?Current knowledge. Am. J. Respir. Cell Mol. Biol. 2001, 25:606-612.
25. Chan J., Xing Y., Magliozzo R.S., Bloom B.R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 1992, 175:1111-1122.
26. MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., Nathan C.F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. U S A 1997, 94:5243-5248.
27. Kwon O.J. The role of nitric oxide in the immune response of tuberculosis. J. Korean Med. Sci. 1997, 12:481-487.
28. Arias M., Rojas M., Zabaleta J., Rodriguez J.I., Paris S.C., Barrera L.F., Garcia L.F. Inhibition of virulent Mycobacterium tuberculosis by Bcg(r) and Bcg(s) macrophages correlates with nitric oxide production. J. Infect. Dis. 1997, 176:1552-1558.
29. Abebe F., Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guerin (BCG) vaccines: is there a link?. Clin. Exp. Immunol. 2006, 145:389-397.
30. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., Barry C.E., Freedman V.H., Kaplan G. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc. Natl. Acad. Sci. U S A 2001, 98:5752-5757.
31. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., Kaplan G., Barry C.E. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431:84-87.
32. Sohn H., Lee K.S., Kim S.Y., Shin D.M., Shin S.J., Jo E.K., Park J.K., Kim H.J. Induction of cell death in human macrophages by a highly virulent Korean Isolate of Mycobacterium tuberculosis and the virulent strain H37Rv. Scand. J. Immunol. 2009, 69:43-50.
33. Russell-Goldman E., Xu J., Wang X., Chan J., Tufariello J.M. A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity phenotypes. Infect. Immun. 2008, 76:4269-4281.
34. Biketov S., Potapov V., Ganina E., Downing K., Kana B.D., Kaprelyants A. The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice. BMC Infect. Dis. 2007, 7:146.
35. Kana B.D., Gordhan B.G., Downing K.J., Sung N., Vostroktunova G., Machowski E.E., Tsenova L., Young M., Kaprelyants A., Kaplan G., Mizrahi V. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol. Microbiol. 2008, 67:672-684.
36. Wu S., Barnes P.F., Samten B., Pang X., Rodrigue S., Ghanny S., Soteropoulos P., Gaudreau L., Howard S.T. Activation of the eis gene in a W-Beijing strain of Mycobacterium tuberculosis correlates with increased SigA levels and enhanced intracellular growth. Microbiology 2009, 155:1272-1281.
37. Sharma M.K., Al-Azem A., Wolfe J., Hershfield E., Kabani A. Identification of a predominant isolate of Mycobacterium tuberculosis using molecular and clinical epidemiology tools and in vitro cytokine responses. BMC Infect. Dis. 2003, 3:3.
38. Keane J., Remold H.G., Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J. Immunol. 2000, 164:2016-2020.
39. Danelishvili L., McGarvey J., Li Y.J., Bermudez L.E. Mycobacterium tuberculosis infection causes different levels of apoptosis and necrosis in human macrophages and alveolar epithelial cells. Cell Microbiol. 2003, 5:649-660.
40. Park J.S., Tamayo M.H., Gonzalez-Juarrero M., Orme I.M., Ordway D.J. Virulent clinical isolates of Mycobacterium tuberculosis grow rapidly and induce cellular necrosis but minimal apoptosis in murine macrophages. J. Leukoc. Biol. 2006, 79:80-86.
41. Balcewicz-Sablinska M.K., Keane J., Kornfeld H., Remold H.G. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. J. Immunol. 1998, 161:2636-2641.
42. Rojas M., Barrera L.F., Puzo G., Garcia L.F. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J. Immunol. 1997, 159:1352-1361.
43. Behar S.M., Divangahi M., Remold H.G. Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?. Nat. Rev. Microbiol. 2010, 8:668-674.
44. Divangahi M., Chen M., Gan H., Desjardins D., Hickman T.T., Lee D.M., Fortune S., Behar S.M., Remold H.G. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 2009, 10:899-906.
45. Herbst S., Schaible U.E., Schneider B.E. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One 2011, 6:e19105.